Skip to content

Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome

Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome in Survivors of Critical Illness: a Pilot Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06983496
Enrollment
24
Registered
2025-05-21
Start date
2025-06-01
Completion date
2026-12-31
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Intensive Care Syndrome (PICS)

Brief summary

The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness. The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery Participants will randomized to receive the study intervention or standard of care.

Interventions

BEHAVIORALPost-ICU Telehealth Follow-up

The post-ICU clinic follow-up will be conducted by a pharmacist via a telehealth visit. A collaborating physician (i.e. intensivist) will provide clinical support and oversight as needed. The appointments will be 30-60 minute telephone/video calls. Participants be assessed for PICS and recommended interventions to improve their care.

Sponsors

Malcom Randall VA Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Adults 18-89 years of age * Required admission to either medical or surgical ICU * Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days * Anticipated discharge to home after hospitalization * Consent from patients themselves or a legally authorized representative if necessary

Exclusion criteria

* Pregnancy * Incarceration/Imprisonment * Life expectancy less than 6 months or enrolled in hospice/palliative care * Anticipated discharge to skilled nursing facility, medical rehabilitation facility, or other long terms care facility * Unable to participate in telehealth

Design outcomes

Primary

MeasureTime frameDescription
Completion of Post-ICU follow-upFrom enrollment to end of follow-up period at seven monthsPercentage of patients completing post-ICU follow-up

Secondary

MeasureTime frameDescription
Quality of life at 6 months using the Short Form Survey (SF-36)From enrollment to 7 monthsMedical Outcomes Study (MOS) 36-Item Short Form Health Survey (SF-36). Scores 0-100, higher scores indicating more favorable health state.
Hospital or ICU re-admissionsEnrollment up to 7 months
Emergency department visitsEnrollment up to 7 months
Mortalitywithin 6 months post-hospital discharge

Countries

United States

Contacts

Primary ContactAndrew J Franck, Pharm.D.
Andrew.Franck@va.gov3523761611

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026